dimethylethylsilylimidazole has been researched along with warfarin in 1 studies
| Studies (dimethylethylsilylimidazole) | Trials (dimethylethylsilylimidazole) | Recent Studies (post-2010) (dimethylethylsilylimidazole) | Studies (warfarin) | Trials (warfarin) | Recent Studies (post-2010) (warfarin) |
|---|---|---|---|---|---|
| 10 | 0 | 9 | 36,573 | 2,143 | 14,728 |
| Protein | Taxonomy | dimethylethylsilylimidazole (IC50) | warfarin (IC50) |
|---|---|---|---|
| Vitamin K epoxide reductase complex subunit 1 | Homo sapiens (human) | 0.0088 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agewall, S; Barton, JC; Drexel, H; Hasegawa, K; Kaski, JC; Kimura, T; Komiyama, M; Lewis, BS; Tamargo, J; Yamamoto, K | 1 |
1 review(s) available for dimethylethylsilylimidazole and warfarin
| Article | Year |
|---|---|
Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events.
Topics: Cardiovascular Agents; Cardiovascular Diseases; Clopidogrel; Coronary Artery Disease; Fibrinolytic Agents; Hemostatics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Lipids; Organosilicon Compounds; Warfarin | 2022 |